Immune-Directed Therapy for Type 1 Diabetes at the Clinical Level: The Immune Tolerance Network (ITN) Experience. Rev Diabet Stud. 2023;9(4). Accessed September 21, 2025. https://www.diabeticstudies.org/index.php/RDS/article/view/185